...
EVGNMICRO

Evogene Ltd.

HealthcareBiotechnology
$0.84
$0.00(+0.44%)
52W$0.81
$2.42
FinancialsValuationvs PHGE
Updated Mar 5, 12:00 AM
RSI36
RS Rating14/99
Beta0.54
Volatility73%
F-Score3/9
Mkt Cap$7M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Evogene Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 14), showing significant lag compared to the market leaders. Earnings growth of 134% provides fundamental context to the price action. Investors should exercise caution due to high volatility (73% annualized), which requires wider risk management.

Relative Strength
14
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
0.54
vs S&P 500
DEFENSIVE
52W Position
2%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.01
50 SMA > 100 SMA$1.09
100 SMA > 150 SMA$1.14
150 SMA > 200 SMA$1.19

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.94-10.54%BELOW
50 SMA$1.01-16.77%BELOW
100 SMA$1.09-23.37%BELOW
150 SMA$1.14-26.58%BELOW
200 SMA$1.19-29.43%BELOW

Price Performance

1D+0.4%
1W-2.6%
1M-23.8%
3M-24.5%
6M-30.2%
YTD-25.8%
1Y-40.6%
3Y-51.8%
52-Week Trading Range2% from low
$0.84
52W Low$0.81
52W High$2.42

Technical Indicators

RSI (14)BEARISH
36.0
305070
VCP ScoreCOOL
5/10
Base depth: 51.9%

Risk Profile

Beta
0.54
52W Vol
73%
ATR
$0.08
Max DD (1Y)
-64%

Volume Analysis

Today
32.4K
50D Avg
546.6K
Vol Ratio
0.06x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+105%
$0.06
Q1'25+50%
$-0.38
Q2'25+42%
$-0.62
Q3'25+134%
$0.44
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-5.20%
5 Years:+62.42%
3 Years:+109.17%
TTM:-26.18%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+88.78%

Stock Price CAGR

10 Years:-35.77%
5 Years:-55.08%
3 Years:-51.84%
1 Year:-40.57%

Return on Equity

10Y Avg:-42.2%
5Y Avg:-58.3%
3Y Avg:-68.4%
Last Year:-15.9%

Key Metrics

Market Cap$7M
Gross Margin39.8%
Net Margin-1.9%
Piotroski F-Score3/9

More EVGN Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

EVGN vs PHGEPHGEARMPMCRBSYBX

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 14 meansEVGN outperformed 14% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.54 means 46% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 3/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is EVGN in an uptrend right now?

EVGN has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is EVGN overbought or oversold?

EVGN's RSI (14) is 36. The stock is in neutral territory, neither overbought nor oversold.

Is EVGN outperforming the market?

EVGN has a Relative Strength (RS) Rating of 14 out of 99. EVGN is currently lagging the broader market.

Where is EVGN in its 52-week range?

EVGN is trading at $0.84, which is 35% of its 52-week high ($2.42) and 2% above its 52-week low ($0.81).

How volatile is EVGN?

EVGN has a Beta of 0.54 and 52-week volatility of 73%. It's less volatile than the S&P 500 - generally more stable.